Cooperative Agreement NU58DP006263

This federal Cooperative Agreement award of $600,000 was provided by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award was made to the National Association of Chronic Disease Directors, Inc. (NACDD), a non-profit organization focused on public health, chronic disease prevention, and health promotion. The purpose of this 5-year award, effective September 30, 2024, is to build capacity to increase...

This Cooperative Agreement award for $600,000 from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) is focused on Building Capacity to Increase Commercial Tobacco Cessation - Component 3. The award recipient is the National Association of Chronic Disease Directors, Inc. (NACDD), a non-profit organization that partners with federal agencies, particularly the CDC, to provide technical assistance, capacity building, and...

The Pennsylvania Department of Health (PADOH) was awarded a $1,345,840 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) federal grant program. The award, with an effective date of September 30, 2024 and an ultimate completion date of June 29, 2029, will support PADOH's efforts to provide technical assistance and training to tobacco prevention contractors, service providers, and...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $599,996 Cooperative Agreement to the North American Quitline Consortium under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award is intended to strengthen and sustain quitline capacity for equitable impact, with a performance period from September 30, 2024 to September 30, 2029. This cooperative agreement will support public health initiatives focused on controlling communicable diseases, chronic...

This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under CFDA Program 93.116 - Project Grants and Cooperative Agreements for Tuberculosis Control Programs provides $1,160,515.00 in funding to the State of North Carolina Department of Health & Human Services (NC DHHS) to bolster the state's tuberculosis (TB) prevention, control, and elimination efforts. The award period runs from January 1, 2025 to December 31, 2029. Key objectives include...

The Centers for Disease Control and Prevention (CDC) awarded a $3,098,000 Cooperative Agreement to the Public Health Law Center Inc. under the "Centers for Disease Control and Prevention Collaboration with Academia to Strengthen Public Health" federal grant program (CFDA 93.967). This 5-year award, effective from August 1, 2024 to July 31, 2029, supports the Center's efforts to enhance public health infrastructure, workforce capabilities, and data systems across the United States....

This federal Cooperative Agreement award was provided by the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The $853,115 award, with a performance period from January 1, 2025 to December 31, 2029, supports the Ohio Department of Health (ODH) in conducting statewide tuberculosis (TB) surveillance, providing technical assistance to local TB control units, offering financial support for TB care,...

This federal Project Grant award of $395,051 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) is supporting a 2-year research project to evaluate the implementation and short-term impact of a new policy in New Jersey that requires tobacco retailers to sell nicotine replacement therapy (NRT) products. The study aims to: 1) determine whether NRT compliance varies by neighborhood characteristics using store audits and spatial analyses, and 2) explore...

This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will assess the effects of FDA tobacco product risk continuum messaging on adult users of combustible tobacco products and youth/young adults. The project aims to: 1) generate rankings of messages and identify effective message features based on perceived effectiveness and...

This Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116), will fund the Nevada Division of Public and Behavioral Health's (DPBH) tuberculosis (TB) prevention, control, and elimination efforts. The $517,839 award, effective January 1, 2025 through December 31, 2029, will support activities to improve TB diagnosis and treatment, increase reporting and...